Terms And Conditions
  1. Home
  2. Terms And Conditions
Anika Therapeutics, Inc. (NASDAQ: ANIK): Pivo...
By ACE Investors / 21 Aug 2025
Read More
Microba Life Sciences Limited (ASX: MAP): Con...
By ACE Investors / 20 Aug 2025
Read More
Lumos Diagnostics (ASX: LDX): FebriDx Drives ...
By ACE Investors / 20 Aug 2025
Read More
Nanosonics Limited (ASX: NAN): The recently r...
By ACE Investors / 18 Aug 2025
Read More
GE HealthCare Technologies, Inc. (NASDAQ: GEH...
By ACE Investors / 18 Aug 2025
Read More
EXACT Sciences Corporation (NASDAQ: EXAS): Ac...
By ACE Investors / 15 Aug 2025
Read More
Cleanaway Waste Management Limited (ASX: CWY)...
By ACE Investors / 14 Aug 2025
Read More
Avalo Therapeutics Inc (NASDAQ: AVTX): Advanc...
By ACE Investors / 14 Aug 2025
Read More
Cogstate Limited (ASX: CGS): Established the ...
By ACE Investors / 14 Aug 2025
Read More
PYC Therapeutics (ASX: PYC): PYC is now funde...
By ACE Investors / 13 Aug 2025
Read More
Paradigm Biopharmaceuticals Limited (ASX: PAR...
By ACE Investors / 12 Aug 2025
Read More
Cigna Corp. (NYSE: CI): Targeting a long-term...
By ACE Investors / 11 Aug 2025
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors